Гадене и умора са съобщавани по- често при жени, лекувани с прамипексол (20, 8% и 10, 5% съответно) в сравнение с мъже (6, 7% и 7, 3% съответно).
Nausea and fatigue were more often reported in female patients treated with pramipexole (20.8% and 10.5%, respectively) compared to males (6.7% and 7.3%, respectively).